Novavax (NVAX) Prepaid Assets (2010 - 2026)
Novavax's (NVAX) quarterly Prepaid Assets came in at $25.7 million in Q1 2026, down 63.83% year-on-year from $71.1 million in Q1 2025, and down 4.11% quarter-over-quarter from $26.8 million in Q4 2025.
Novavax (NVAX) Prepaid Assets (2010 - 2026) Analysis & Trends
Novavax's Prepaid Assets history runs 17 years deep, the most recent figure standing at $25.7 million for Q1 2026.
- On a quarterly basis, Prepaid Assets fell 63.83% year-over-year to $25.7 million in Q1 2026; TTM through Mar 2026 was $25.7 million, a 63.83% decrease from a year earlier, with the FY2025 full-year figure at $26.8 million, up 22.51% from the prior year.
- Prepaid Assets slipped to $25.7 million in Q1 2026 per NVAX's latest filing, from $26.8 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $299.3 million in Q2 2022 and bottomed at $21.9 million in Q4 2024.
- The 5-year median for Prepaid Assets is $102.0 million (2024), against an average of $130.7 million.
- Across the five-year window, Prepaid Assets jumped 195.94% in 2023 and slumped 90.32% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $76.4 million in 2022, then soared by 195.94% to $226.0 million in 2023, then slumped by 90.32% to $21.9 million in 2024, then gained by 22.51% to $26.8 million in 2025, then retreated by 4.11% to $25.7 million in 2026.
- Per Business Quant, the three latest NVAX Prepaid Assets figures stand at $25.7 million (Q1 2026), $26.8 million (Q4 2025), and $45.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Novavax | 788.01 Mn | -2.33 Mn | 108.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.71 Mn |
| Dec 31, 2025 | 26.82 Mn |
| Sep 30, 2025 | 45.53 Mn |
| Jun 30, 2025 | 59.82 Mn |
| Mar 31, 2025 | 71.10 Mn |
| Dec 31, 2024 | 21.89 Mn |
| Sep 30, 2024 | 80.00 Mn |
| Jun 30, 2024 | 102.01 Mn |
| Mar 31, 2024 | 198.92 Mn |
| Dec 31, 2023 | 226.02 Mn |
| Sep 30, 2023 | 152.02 Mn |
| Jun 30, 2023 | 192.90 Mn |
| Mar 31, 2023 | 188.71 Mn |
| Dec 31, 2022 | 76.37 Mn |
| Sep 30, 2022 | 274.52 Mn |
| Jun 30, 2022 | 299.31 Mn |
| Mar 31, 2022 | 180.16 Mn |
| Dec 31, 2021 | 44.62 Mn |
| Sep 30, 2021 | 119.05 Mn |
| Jun 30, 2021 | 162.35 Mn |